drugset / Trial / NCT02597023

The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults

NCT02597023

Completed 55 enrolled University of Colorado, Boulder
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy of supplementation with the mitochondria-targeted antioxidant, mitoquinone (MitoQ), for improving physiological function (vascular, motor, and cognitive) in middle-aged and older adults.

Timeline

Start
2015-09
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject MitoQ Small molecule 20 mg Oral

Indications

No indication recorded.